Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 86 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Prevention of Colorectal Cancer Clear all

Conditions: Colon Cancer, Lung Cancer, Prostate Cancer
Interventions: Contact Intervention; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1,256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Houston, Texas • Temple, Texas

Conditions: Colorectal Cancer, Chemotherapy-induced Peripheral Neuropathy
Interventions: Calmangafodipir (2 µmol/kg), Calmangafodipir (5 µmol/kg), Placebo; Drug
Lead sponsor: Egetis Therapeutics AB (publ); Industry
Eligibility: 18 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 11
States / cities: Fresno, California • Orange City, Florida • Wichita, Kansas + 8 more

Conditions: Familial Adenomatous Polyposis
Interventions: Black raspberry (BRB) Slurry, Black Raspberry (BRB) Suppositories, Black Raspberry (BRB) Placebo Slurry; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Colorectal Cancer
Interventions: Acetylsalicylic acid (Aspirin), Sulindac, Ursodiol, Sulindac Placebo; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 40 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Risk for Colorectal Cancer
Interventions: MUC1 - Poly ICLC; Biological
Lead sponsor: Robert Schoen; Other
Eligibility: 40 Years to 70 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Cancer, Colorectal Cancer, Pain
Interventions: Capecitabine, Celecoxib, Radiation Therapy, Placebo; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 13
States / cities: Santa Rosa, California • Grand Rapids, Michigan • Kalamazoo, Michigan + 10 more

Conditions: Colorectal Cancer
Interventions: R-1,3-Butanediol; Dietary Supplement
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pain, Cancer, Colonic Diseases
Interventions: GIC-1001; Drug
Lead sponsor: gicare Pharma Inc.; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 11
States / cities: Scottsdale, Arizona • Anaheim, California • Chula Vista, California + 8 more

Conditions: Colon Cancer, Rectal Cancer
Interventions: Patient Navigator; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 25 Years to 75 Years
Enrollment: 1,900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Colorectal Cancer
Interventions: Ginger Root Extract (Pure Encapsulations), Placebo Capsule; Drug · Dietary Supplement
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Colorectal Neoplasm, Colonic Polyps
Interventions: Close focus HD NBI Colonoscopy System; Device
Lead sponsor: VA Palo Alto Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 558 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Palo Alto, California • Kansas City, Missouri

Conditions: Colorectal Cancer
Interventions: Electronic Consult System; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 9
States / cities: Phoenix, Arizona • Tucson, Arizona • Denver, Colorado + 6 more

Conditions: Colorectal Neoplasms, Diarrhea
Interventions: Investigational drug, Irinotecan, 5-fluorouracil, Leucovorin; Drug
Lead sponsor: Celgene Corporation; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 28
States / cities: Little Rock, Arkansas • Anaheim, California • Concord, California + 24 more

Conditions: Colorectal Adenomatous Polyps
Interventions: Calcium and vitamin D3 combined, Placebo, Calcium, Vitamin D3; Dietary Supplement · Drug
Lead sponsor: Emory University; Other
Eligibility: 30 Years to 74 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome, Relatives
Interventions: Genetic Counseling, Genetic Testing, Laboratory Biomarker Analysis, Mutation Carrier Screening; Other · Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,001 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 9
States / cities: Akron, Ohio • Canton, Ohio • Cincinnati, Ohio + 3 more

Conditions: Colon Cancer
Interventions: grapes; Dietary Supplement
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Orange, California

Conditions: Cascade Testing, Lynch Syndrome, Decision Making, Colorectal Cancer, Uterine Cancer, Cancer Prevention
Interventions: Information Letter and Booklet, Information Letter; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Colon Cancer, Rectal Cancer
Interventions: AlloMEM™; Biological
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Colorectal Cancer, Prevention
Interventions: On-site Fecal Immunochemical Test (FIT) Kit Distribution, On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 45 Years to 75 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Omaha, Nebraska

Conditions: Colorectal Carcinoma
Interventions: NPT-PLA, Usual Quality Improvement; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Colorectal Neoplasms
Interventions: Eflornithine placebo & sulindac placebo, eflornithine & sulindac placebo, Eflornithine placebo & sulindac, Eflornithine plus sulindac; Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2032
U.S. locations: 989
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 616 more

Conditions: Colorectal Cancer
Interventions: Text Messaging; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 45 Years to 75 Years
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer, Stage 0 Non-Small Cell Lung Cancer, Stage I Colorectal Cancer, Stage IA Breast Cancer, Stage IA Non-Small Cell Lung Carcinoma, Stage IB Breast Cancer, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Breast Cancer, Stage IIA Colorectal Cancer, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Breast Cancer, Stage IIB Colorectal Cancer, Stage IIB Non-Small Cell Lung Carcinoma, Stage IIC Colorectal Cancer, Stage IIIA Breast Cancer, Stage IIIA Colorectal Cancer, Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Breast Cancer, Stage IIIB Colorectal Cancer, Stage IIIB Non-Small Cell Lung Cancer, Stage IIIC Breast Cancer, Stage IIIC Colorectal Cancer, Stage IV Breast Cancer, Stage IV Non-Small Cell Lung Cancer, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer
Interventions: Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration; Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 3,665 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 159
States / cities: Jonesboro, Arkansas • Martinez, California • Augusta, Georgia + 134 more

Conditions: Colorectal Cancer, Obesity
Interventions: Physical Activity, Energy Restriction, Physical Activity and Energy Restriction; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 50 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Nashville, Tennessee

Search by objective public record fields.

Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Adherence to Colon Cancer Screening (ACCS)

Ginger for Colorectal Cancer Prevention

Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy Study

Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Calcium and Vitamin D vs Markers of Adenomatous Polyps

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention

Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome

Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy

A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans

Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

S0820, Adenoma and Second Primary Prevention Trial

Text-based Colorectal Cancer Prevention Pilot

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Energy Balance Interventions for Colorectal Cancer Prevention